Bayer flags US$750m higher Roundup settlement bill
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[FRANKFURT] Drugs and farming pesticides maker Bayer said the costs of its settlement over claims its Roundup weedkiller causes cancer, initially put at US$11 billion, would be US$750 million higher.
Bayer struck an agreement in principle with US plaintiff's lawyers in June but a judge later took issue with a side arrangement on future cases that may yet be lodged, known as a class plan.
"Bayer took an additional provision in the third quarter to cover the increased cost of a revised class plan, as it is far enough along in the negotiations to know that the new plan will come in at approximately US$2 billion, an increase over the original cost of US$1.25 billion," Bayer said in a statement on Monday.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant